G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2021 19:30 ET | Source: G1 Therapeutics G1 Therapeutics Research Triangle Park, North Carolina, UNITED STATES RESEARCH TRIANGLE PARK, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 80,400 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (t...